Abstract
AbstractIn this study, a series of trinitroaniline derivatives (TNA1‐8) were synthesized and investigated as potential antitumor agents for enzyme‐prodrug therapy. Enzymatic efficiency of Ssap‐NtrB on prodrug candidates was determined with HPLC analysis and kinetic studies. The anti‐proliferative properties of compounds were determined against four cancer cell lines (Hep3B, PC3, HT‐29, and Saos‐2) and a healthy cell line (HUVEC) via MTT assay. Intracellular and extracellular prodrug‐enzyme treatments were carried out on Hep3B cells. Herewith, the expression of the Ssap‐NtrB gene was confirmed with this study. IC50 values of piperidine and 1,3‐cyclohexyl derivatives (TNA4 and TNA7) were identified as 1.724 nM and 1.640 nM at extracellular conditions. In intracellular conditions, it was determined as 0.293 μM and 0.393 μM, respectively. In summary, 2,4,6‐trinitroaniline derivatives, especially compounds TNA4 and TNA7 might be used as prodrug candidates along with Ssap‐NtrB for hepatocellular carcinoma therapy and the development of new prodrugs at cancer treatments.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
